abstract |
(57) [Summary]nProvided are compounds and methods for alleviating or treating a disease or condition in which altering the activity of a muscarinic m1 receptor is effective. In the method of the invention, a therapeutically effective amount of a selective muscarinic ml agonist compound is administered to a patient in need of such treatment. |